You just read:

Daiichi Sankyo, Inc. and Inspirion Delivery Sciences LLC Announce Plans for Commercialization of RoxyBond™ (oxycodone hydrochloride) Tablets CII in the U.S.

News provided by

Daiichi Sankyo, Inc.

May 30, 2017, 08:00 ET